The growing prevalence of hyperuricemia with the increase in age is expected to be the major driving factor for the growth of the xanthine oxidase inhibitors market over the forecast period. Lifestyle ...

In both men and women, higher levels of serum xanthine oxidase activity were linked with an increased risk for type 2 diabetes, according to findings from a prospective cohort study conducted in ...

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Xanthine Oxidase Inhibitors. Xanthine Oxidase ...

Present understanding of the true nature of hemochromatosis is so inadequate that conceptual problems seem to arise with each new pertinent observation. The case of xanthinuria and hemochromatosis ...

Xanthine oxidase reported to modulate progression of chronic kidney disease, diabetic kidney disease, polycystic kidney disease, and other indications CALGARY, Alberta, Aug. 29, 2024 (GLOBE ...

SINCE its clinical introduction in 1964, allopurinol (4-hydroxypyrazolo-[3,4-d]-pyrimidine) has been increasingly used for the treatment of hyperuricemia of gout,1 , 2 many neoplastic diseases and ...

"Combination treatment of lesinurad and febuxostat represents a new therapeutic option for patients with severe gout who cannot achieve the serum urate treatment target with xanthine oxidase ...

BIOLOGICAL and chemical work with purified xanthine oxidase from cows' milk is handicapped by the loss of its enzymic activity on storage1,2. The rate of deterioration, which increases with the ...

Xanthine oxidase inhibitors (XOIs) do not improve uric acid-associated risks for cardiovascular events or deaths among adults, according to a meta-analysis of data pooled from 61 randomized ...